Kaya Limited Q1FY27 Revenue Up 14% to ₹60.1 Crore, Loss Widens to ₹15.2 Crore
Kaya Limited's Q1 FY27 revenue grew 14% to ₹60.1 crore. Clinic business revenue increased 16%, driven by key service categories. Skin, hair, and product businesses also showed growth. The company reported a net loss of ₹15.2 crore, wider than Q1 FY26's ₹14.2 crore loss, citing GST 2.0 changes impacting input tax credit.
The revenue growth is a positive indicator for the company's operations. However, the widening loss due to external regulatory changes like GST 2.0 could pose a challenge and impact future profitability.
While revenue shows positive growth, the net loss has widened, indicating a mixed financial performance. The reasons cited for the wider loss are external factors.
Kaya Limited announced its financial results for the quarter ended June 30, 2026, reporting a revenue from operations of ₹60.1 crore, marking a 14% growth compared to the corresponding quarter in the previous fiscal year (Q1 FY26).
The company's clinic business demonstrated robust growth, with revenue increasing by 16% over Q1 FY26. This growth was primarily driven by key service categories including Brightening & Pigmentation, Acne & Scars, and Anti-Aging. The skin business saw a significant rise of 19%, while the hair business grew by 17% over the same period.
The product business also contributed to the overall growth, registering a 16% increase in revenue, mainly due to strong performance in categories such as Nutraceutical, Lighter and Brighter, and Anti-Aging.
Despite the revenue growth, the Profit/(Loss) after tax for Q1 FY27 was ₹(15.2) crore, compared to a Profit/(Loss) after tax of ₹(14.2) crore in Q1 FY26. The company attributed the wider loss primarily to the impact of GST 2.0 changes effective September 2025, which restricted input tax credit availability.
Kaya Limited, with over 20 years of legacy, operates 82 clinics across India, offering over 600 service lines and a product mix of over 75 items, supported by more than 100 dermatologists.
What to do with a filing like this
Kaya Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kaya Limited. Read the original for the full detail.